Skip to main content

Table 2 Description of included studies – In-house PCR testsa

From: Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis

Country, year

Independent comparison

Cross-sectional study design

Double or single blind

Consecutive or random sample

Prospective data collection

Type of testb sequence)

(target Reference standardc

Study qualityd

No. of pleural specimens or Subjects with TB/No. without TB

Sensitivity (95% CI)e

Specificity (95% CI)

Brazil,[24] 2000

Yes

No

Yes

Yes

Partly

PCR (16S rRNA)

Culture/clinical

Medium

28/17

0.89 (0.71, 0.97)

1.00 (0.80, 1.00)

Spain,[25] 2000

Yes

No

Yes

Yes

Yes

PCR (IS6110)

Culture/clinical

Medium

9/16

0.89 (0.51, 0.99)

1.00 (0.79, 1.00)

China,[27] 1996

Yes

Yes

Unknown

Yes

Unknown

PCR (IS6110/38 kDa)

Culture

Medium

25/76

0.44 (0.25, 0.65)

0.99 (0.92, 1.00)

India,[29] 1998

Yes

No

Yes

Unknown

Yes

PCR (MPB64)

Culture/clinical

Medium

28/16

0.61 (0.41, 0.78)

0.94 (0.68, 1.00)

France,[30] 1992

Yes

No

No

No

Partly

PCR (IS6110)

Culture/biopsy

Low

15/10

0.60 (0.33, 0.82)

1.00 (0.69, 1.00)

France,[30] 1992

Yes

No

No

No

Partly

PCR (65 kDa)

Culture/biopsy

Low

15/10

0.20 (0.05, 0.48)

1.00 (0.69, 1.00)

S. Africa,[31] 1992 Yes

Yes

Yes

Yes

Yes

Yes

PCR (336 bp repetitive sequence)

Culture/biopsy

High

50/31

0.82 (0.68, 0.91)

0.77 (0.59, 0.90)

S. Africa,[32] 1990 Yes

Yes

Yes

Unknown

Unknown

Unknown

PCR (336 bp repetitive sequence)

Culture

Medium

11/5

1.00 (0.72, 1.00)

1.00 (0.48, 1.00)

India,[36] 2001

Yes

Yes

Yes

No

Yes

PCR (IS6110)

Culture

Medium

4/26

0.25 (0.01, 0.78)

0.96 (0.79, 1.00)

Chile,[38] 1993

Yes

No

Yes

Unknown

Unknown

PCR (65 kDa)

Culture/microscopy

Medium

15/11

0.93 (0.66, 1.00)

1.00 (0.72, 1.00)

Mexico et al,[39] 2001

Yes

Yes

Yes

Yes

Yes

PCR (465 bp sequence)

Culture

High

3/12

0.33 (0.02, 0.87)

0.83 (0. 51, 0.97)

France,[40] 1996

Yes

No

No

Yes

Yes

PCR (IS6110)

Culture/biopsy

Medium

17/25

0.76 (0.50, 0.92)

1.00 (0.86, 1.00)

Brazil,[41] 2000

Yes

Yes

Yes

Yes

Partly

PCR (MPB64)

Culture/biopsy

High

19/11

0.68 (0.44, 0.86)

0.91 (0.57, 0.99)

Japan,[43] 1993

Yes

Yes

Unknown

Unknown

Unknown

PCR (38 kDa)

Culture

Low

5/105

0.80 (0.30, 0.99)

0.93 (0.86, 0.97)

India,[45] 2001

Yes

Yes

Yes

Unknown

No

PCR (150 bp sequence)

Microscopy/biopsy

High

20/40

0.70 (0.46, 0.87)

1.00 (0.91, 1.00)

Taiwan,[47] 1990

Yes

Yes

Unknown

Unknown

Unknown

PCR (65 kDa)

Culture

Medium

11/37

1.00 (0.72, 1.00)

0.78 (0.61, 0.90)

India,[48] 2000

Yes

Yes

Unknown

Unknown

Unknown

PCR (IS6110/TRC4)

Culture/microscopy

Medium

30/20

1.00 (0.88, 1.00)

0.70 (0.46, 0.87)

Mexico,[50] 2000

Yes

No

Yes

Yes

Yes

PCR (IS6110)

Culture/biopsy

High

17/56

0.94 (0.69, 1.00)

1.00 (0.94, 1.00)

Spain,[51] 1995

Yes

No

Yes

Yes

Yes

PCR (IS6110)

Culture/biopsy

High

21/86

0.81 (0.58, 0.94)

0.98 (0.91, 1.00)

Thailand,[53] 2000

Yes

Yes

Unknown

Yes

Yes

PCR (16S rRNA)

Culture/biopsy

High

36/62

0.72 (0.55, 0.85)

0.53 (0.40, 0.66)

Singapore,[57] 1995

Yes

No

Unknown

Unknown

Unknown

PCR (IS6110)

Culture/biopsy

Low

10/13

0.70 (0.36, 0.92)

1.00 (0.75, 1.00)

Singapore,[57] 1995

Yes

No

Unknown

Unknown

Unknown

PCR (MPB64)

Culture/biopsy

Low

10/13

0.70 (0.36, 0.92)

1.00 (0.75, 1.00)

Singapore,[56] 1997

Yes

Yes

Yes

Yes

Yes

PCR (IS6110)

Culture/clinical

High

16/49

1.00 (0.79, 1.00)

0.88 (0.75, 0.95)

India,[58] 1995

Yes

No

Yes

No

Yes

PCR (150 bp sequence)

Clinical/biopsy

Medium

38/29

0.63 (0.46, 0.78)

0.93 (0.76, 0.99)

Colombia,[59] 2000

Yes

Yes

Yes

Yes

No

PCR (IS6110)

Culture/biopsy

High

42/70

0.74 (0.58, 0.86)

0.90 (0.80, 0.96)

Spain,[60] 1998

Yes

Yes

Yes

No

Yes

PCR (IS6110)

Culture/biopsy

High

33/98

0.42 (0.26, 0.61)

0.99 (0.94, 1.00)

  1. aIncorporates additional information provided by authors of the primary studies bType of test: PCR: polymerase chain reaction cReference standard: culture refers to culture of pleural fluid/sputum/biopsy; biopsy refers to pleural biopsy; clinical refers to data such as signs and symptoms, response to therapy, and pleural fluid analysis dSee text for description of quality assessment eCI: Confidence Interval